Literature DB >> 24920680

SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.

Lance M Bollinger1, Carol A Witczak1, Joseph A Houmard2, Jeffrey J Brault3.   

Abstract

Muscle-specific RING finger-1 (MuRF-1), a ubiquitin ligase and key regulator of proteasome-dependent protein degradation, is highly expressed during skeletal muscle atrophy. The transcription factor forkhead box O3 (FoxO3) induces MuRF-1 expression, but the direct role of other major atrophy-related transcription factors, such as SMAD3, is largely unknown. The goal of this study was to determine whether SMAD3 individually regulates, or with FoxO3 coordinately regulates, MuRF-1 expression. In cultured myotubes or human embryonic kidney cells, MuRF-1 mRNA content and promoter activity were increased by FoxO3 but not by SMAD3 overexpression. However, FoxO3 and SMAD3 coexpression synergistically increased MuRF-1 mRNA and promoter activity. Mutation of the SMAD-binding element (SBE) in the proximal MuRF-1 promoter or overexpression of a SMAD3 DNA-binding mutant attenuated FoxO3-dependent MuRF-1 promoter activation, showing that SMAD binding to DNA is required for optimal activation of FoxO3-induced transcription of MuRF-1. Using chromatin immunoprecipitation, SMAD3 DNA binding increased FoxO3 abundance and SBE mutation reduced FoxO3 abundance on the MuRF-1 promoter. Furthermore, SMAD3 overexpression dose-dependently increased FoxO3 protein content, and coexpression of FoxO3 and SMAD3 synergistically increased FoxO-dependent gene transcription [assessed with a FoxO response element (FRE)-driven reporter]. Collectively, these results show that SMAD3 regulates transcription of MuRF-1 by increasing FoxO3 binding at a conserved FRE-SBE motif within the proximal promoter region, and by increasing FoxO3 protein content and transcriptional activity. These data are the first to indicate that two major transcription factors regulating protein degradation, FoxO3 and SMAD3, converge to coordinately and directly regulate transcription of MuRF-1.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  cell culture; protein degradation; protein-DNA interaction; transcription factors; ubiquitin ligase

Mesh:

Substances:

Year:  2014        PMID: 24920680      PMCID: PMC4121583          DOI: 10.1152/ajpcell.00391.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  36 in total

1.  Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.

Authors:  Sarah A Reed; Pooja B Sandesara; Sarah M Senf; Andrew R Judge
Journal:  FASEB J       Date:  2011-11-18       Impact factor: 5.191

2.  Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.

Authors:  Sudarsanareddy Lokireddy; Craig McFarlane; Xiaojia Ge; Huoming Zhang; Siu Kwan Sze; Mridula Sharma; Ravi Kambadur
Journal:  Mol Endocrinol       Date:  2011-09-29

3.  Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins.

Authors:  Sudarsanareddy Lokireddy; Vincent Mouly; Gillian Butler-Browne; Peter D Gluckman; Mridula Sharma; Ravi Kambadur; Craig McFarlane
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-07       Impact factor: 4.249

4.  Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy.

Authors:  Jeffrey J Brault; Jakob G Jespersen; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

5.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.

Authors:  Anne Ulrike Trendelenburg; Angelika Meyer; Daisy Rohner; Joseph Boyle; Shinji Hatakeyama; David J Glass
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

6.  FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70.

Authors:  Sarah M Senf; Stephen L Dodd; Andrew R Judge
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-28       Impact factor: 4.249

7.  Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.

Authors:  Michael R Morissette; Stuart A Cook; Cattleya Buranasombati; Michael A Rosenberg; Anthony Rosenzweig
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-16       Impact factor: 4.249

8.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

9.  During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.

Authors:  Shenhav Cohen; Jeffrey J Brault; Steven P Gygi; David J Glass; David M Valenzuela; Carlos Gartner; Esther Latres; Alfred L Goldberg
Journal:  J Cell Biol       Date:  2009-06-08       Impact factor: 10.539

10.  Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages.

Authors:  Enrica Calura; Stefano Cagnin; Anna Raffaello; Paolo Laveder; Gerolamo Lanfranchi; Chiara Romualdi
Journal:  BMC Genomics       Date:  2008-12-23       Impact factor: 3.969

View more
  17 in total

1.  Effects of ageing on expression of the muscle-specific E3 ubiquitin ligases and Akt-dependent regulation of Foxo transcription factors in skeletal muscle.

Authors:  Akira Wagatsuma; Masataka Shiozuka; Yuzo Takayama; Takayuki Hoshino; Kunihiko Mabuchi; Ryoichi Matsuda
Journal:  Mol Cell Biochem       Date:  2015-11-20       Impact factor: 3.396

2.  AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism.

Authors:  Joshua D Stone; Andrew W Holt; Jackson R Vuncannon; Jeffrey J Brault; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

Review 3.  Edward F. Adolph Distinguished Lecture. Skeletal muscle atrophy: Multiple pathways leading to a common outcome.

Authors:  Sue C Bodine
Journal:  J Appl Physiol (1985)       Date:  2020-07-09

4.  Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.

Authors:  Paul T Winnard; Santosh K Bharti; Marie-France Penet; Radharani Marik; Yelena Mironchik; Flonne Wildes; Anirban Maitra; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

Review 5.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

6.  Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin-proteasome and autophagic/lysosomal proteolytic flux.

Authors:  Lance M Bollinger; Jonathan J S Powell; Joseph A Houmard; Carol A Witczak; Jeffrey J Brault
Journal:  Obesity (Silver Spring)       Date:  2015-06       Impact factor: 5.002

7.  Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model.

Authors:  Jenna N Regan; Carter Mikesell; Steven Reiken; Haifang Xu; Andrew R Marks; Khalid S Mohammad; Theresa A Guise; David L Waning
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-19       Impact factor: 5.555

Review 8.  Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.

Authors:  Nathan A Holland; Jake T Francisco; Sean C Johnson; Joshua S Morgan; Troy J Dennis; Nishitha R Gadireddy; David A Tulis
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-23

Review 9.  Muscle Wasting Diseases: Novel Targets and Treatments.

Authors:  Regula Furrer; Christoph Handschin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-08-27       Impact factor: 13.820

10.  Prediction and Validation of Transcription Factors Modulating the Expression of Sestrin3 Gene Using an Integrated Computational and Experimental Approach.

Authors:  Rajneesh Srivastava; Yang Zhang; Xiwen Xiong; Xiaoning Zhang; Xiaoyan Pan; X Charlie Dong; Suthat Liangpunsakul; Sarath Chandra Janga
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.